A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome

Stopped early · Phase 3

Conditions studied: Dravet Syndrome (DS), Lennox Gastaut Syndrome (LGS)

In brief

The main aim of the study is to learn if soticlestat, when given as an add-on therapy, reduces the number of seizures in children and adults with Dravet Syndrome (DS) or Lennox-Gastaut Syndrome (LGS). Participants will receive their standard anti-seizure therapy, plus tablets of soticlestat. There will be scheduled visits and follow-up phone calls throughout the study.

Key facts

Study ID
NCT05163314
Run by
Takeda
People needed
352
Starts
2022-03-04
Expected to finish
2025-09-24
Last updated by the study team
2026-06-09

Who can join

Age: 2 and older, up to 56. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.